Drug Approval | February 18, 2023
Zydus receives final approval from USFDA for Sirolimus Tablets, 1 mg and 2 mg
Sirolimus Tablets had annual sales of USD 69 million in the United States (IQVIA MAT Dec. 2022)
Sirolimus Tablets had annual sales of USD 69 million in the United States (IQVIA MAT Dec. 2022)
This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Her appointment further strengthens the CDMO’s strategy to become the nutraceutical R&D hub for brands looking for agile partners with large scientific and development resources
The combined company will be able to better serve both our global and regional customers with local production
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
The target demographic will be those between the ages of 30 and 65 years
Subscribe To Our Newsletter & Stay Updated
